Cited by 351

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Platinum Drug Distribution in Cancer Cells and Tumors

Klein, Alice V., Hambley, Trevor W.·2009·Chemical Reviews

Open this paper in CoChat — free account

Abstract

ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTPlatinum Drug Distribution in Cancer Cells and TumorsAlice V. Klein and Trevor W. Hambley*View Author Information School of Chemistry, The University of Sydney, NSW 2006, Australia* Corresponding author. E-mail: [email protected]. Phone: 61-2-9351-2830. Fax: 61-2-9351-3329.Cite this: Chem. Rev. 2009, 109, 10, 4911–4920Publication Date (Web):August 28, 2009Publication History Received19 March 2009Published online28 August 2009Published inissue 14 October 2009https://pubs.acs.org/doi/10.1021/cr9001066https://doi.org/10.1021/cr9001066review-articleACS PublicationsCopyright © 2009 American Chemical SocietyRequest reuse permissionsArticle Views7146Altmetric-Citations302LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Antineoplastic agents,Cells,Fluorescence,Platinum,Tumors Get e-Alerts

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1021/cr9001066

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Drug penetration in solid tumours
Minchinton, A. I., & Tannock, I. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1893 · Cited by 2,805
Molecular mechanisms of resistance and toxicity associated with platinating agents
Rabik, C. A., & Dolan, M. E. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.09.006 · Cited by 1,564
Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation
Fichtinger-Schepman, A. M. J., Van der Veer, J. L., Den Hartog, J. H. J., Lohman, P. H. M., & Reedijk, J. (1985) · Biochemistry · doi:10.1021/bi00324a025 · Cited by 1,024
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
Ishida, S., Lee, J., Thiele, D. J., & Herskowitz, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162491399 · Cited by 927
Mechanisms of resistance to cisplatin
Kartalou, M., & Essigmann, J. M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00141-5 · Cited by 869
Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin
Takahara, P. M., Rosenzweig, A. C., Frederick, C. A., & Lippard, S. J. (1995) · Nature · doi:10.1038/377649a0 · Cited by 769
Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches
Galanski, M. S., Jakupec, M. A., & Keppler, B. K. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054637626 · Cited by 721
Platinum(IV) antitumour compounds: their bioinorganic chemistry
Hall, M. D., & Hambley, T. W. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00026-7 · Cited by 622
Self-citation
Soluble Single-Walled Carbon Nanotubes as Longboat Delivery Systems for Platinum(IV) Anticancer Drug Design
Feazell, R. P., Nakayama-Ratchford, N., Dai, H., & Lippard, S. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073231f · Cited by 616
Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells
Safaei, R., Larson, B. J., Cheng, T. C., Gibson, M. A., Otani, S., Naerdemann, W., & Howell, S. B. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0102 · Cited by 564
Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications
Maeda, H., Fang, J., Inutsuka, T., & Kitamoto, Y. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00271-0 · Cited by 537
The Discovery and Development of Cisplatin
Alderden, R. A., Hall, M. D., & Hambley, T. W. (2006) · Journal of Chemical Education · doi:10.1021/ed083p728 · Cited by 532
Self-citation
The SLC22 drug transporter family
Koepsell, H., & Endou, H. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1089-9 · Cited by 525
Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy.
Tannock, I. F., Lee, C. M., Tunggal, J. K., Cowan, D., & Egorin, M. J. (2002) · PubMed · Cited by 505
The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
Hall, M. D., Okabe, M., Shen, D.-W., Liang, X.-J., & Gottesman, M. M. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.080907.180426 · Cited by 474
Basis for Design and Development of Platinum(IV) Anticancer Complexes
Hall, M. D., Mellor, H. R., Callaghan, R., & Hambley, T. W. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070280u · Cited by 458
Self-citation
Organic Cation Transporters Are Determinants of Oxaliplatin Cytotoxicity
Zhang, S., Lovejoy, K. S., Shima, J. E., Lagpacan, L. L., Shu, Y., Lapuk, A., Chen, Y., Komori, T., Gray, J. W., Chen, X., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0769 · Cited by 431
Increased Expression of the Copper Efflux Transporter ATP7A Mediates Resistance to Cisplatin, Carboplatin, and Oxaliplatin in Ovarian Cancer Cells
Samimi, G., Safaei, R., Katano, K., Holzer, A. K., Rochdi, M., Tomioka, M., Goodman, M., & Howell, S. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0137 · Cited by 358
Short-termcis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells
Mann, S. C., Andrews, P. A., & Howell, S. B. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00684878 · Cited by 349
Cisplatin and Oxaliplatin, but Not Carboplatin and Nedaplatin, Are Substrates for Human Organic Cation Transporters (SLC22A1–3 and Multidrug and Toxin Extrusion Family)
Yonezawa, A., Masuda, S., Yokoo, S., Katsura, T., & Inui, K.-I. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110346 · Cited by 344
Contribution of the Major Copper Influx Transporter CTR1 to the Cellular Accumulation of Cisplatin, Carboplatin, and Oxaliplatin
Holzer, A. K., Manorek, G. H., & Howell, S. B. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.022624 · Cited by 322
Solution Structure of a Cisplatin-Induced DNA Interstrand Cross-Link
Huang, H., Zhu, L., Reid, B. R., Drobny, G. P., & Hopkins, P. B. (1995) · Science · doi:10.1126/science.270.5243.1842 · Cited by 314
Transporters involved in the elimination of drugs in the kidney: Organic anion transporters and organic cation transporters
Dresser, M. J., Leabman, M. K., & Giacomini, K. M. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200104)90:4<397::aid-jps1000>3.0.co;2-d · Cited by 290
The roles of copper transporters in cisplatin resistance
Kuo, M. T., Chen, H. H. W., Song, I.-S., Savaraj, N., & Ishikawa, T. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9045-3 · Cited by 283
Synthesis, Characterization, and Cytotoxicity of a Series of Estrogen-Tethered Platinum(IV) Complexes
Barnes, K. R., Kutikov, A., & Lippard, S. J. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.024 · Cited by 263
The Copper Influx Transporter Human Copper Transport Protein 1 Regulates the Uptake of Cisplatin in Human Ovarian Carcinoma Cells
Holzer, A. K., Samimi, G., Katano, K., Naerdemann, W., Lin, X., Safaei, R., & Howell, S. B. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001198 · Cited by 245
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
Lovejoy, K. S., Todd, R. C., Zhang, S., McCormick, M. S., D'Aquino, J. A., Reardon, J. T., Sancar, A., Giacomini, K. M., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803441105 · Cited by 238
Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin
(1992) · Lung Cancer · doi:10.1016/0169-5002(92)90185-m · Cited by 237
A Phase I and Pharmacological Study of the Platinum Polymer AP5280 Given as an Intravenous Infusion Once Every 3 Weeks in Patients with Solid Tumors
Rademaker-Lakhai, J. M., Terret, C., Howell, S. B., Baud, C. M., de Boer, R. F., Pluim, D., Beijnen, J. H., Schellens, J. H. M., & Droz, J.-P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0315 · Cited by 214
Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin
He, Q., Liang, C. H., & Lippard, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100108697 · Cited by 209
GS-X pump is functionally overexpressed in cis-diamminedichloroplatinum (II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation.
Ishikawa, T., Wright, C. D., & Ishizuka, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62016-8 · Cited by 206
Effect of Glutathione on DNA Repair in Cisplatin-Resistant Human Ovarian Cancer Cell Lines
Lai, G.-M., Ozols, R. F., Young, R. C., & Hamilton, T. C. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.7.535 · Cited by 167
Role of copper transporters in the uptake and efflux of platinum containing drugs
Safaei, R. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.07.046 · Cited by 160
Towards Antitumor Active trans‐Platinum Compounds
Aris, S. M., & Farrell, N. P. (2009) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200801118 · Cited by 160
Use of Three-Dimensional Tissue Cultures to Model Extravascular Transport and Predict In Vivo Activity of Hypoxia-Targeted Anticancer Drugs
Hicks, K. O., Pruijn, F. B., Secomb, T. W., Hay, M. P., Hsu, R., Brown, J. M., Denny, W. A., Dewhirst, M. W., & Wilson, W. R. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj306 · Cited by 154
Intracellular Localization and Trafficking of Fluorescein-Labeled Cisplatin in Human Ovarian Carcinoma Cells
Safaei, R., Katano, K., Larson, B. J., Samimi, G., Holzer, A. K., Naerdemann, W., Tomioka, M., Goodman, M., & Howell, S. B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.756.11.2 · Cited by 141
XANES Determination of the Platinum Oxidation State Distribution in Cancer Cells Treated with Platinum(IV) Anticancer Agents
Hall, M. D., Foran, G. J., Zhang, M., Beale, P. J., & Hambley, T. W. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0354770 · Cited by 140
Self-citation
Organic cation transporters
Ciarimboli, G. (2008) · Xenobiotica · doi:10.1080/00498250701882482 · Cited by 128
The Copper Export Pump ATP7B Modulates the Cellular Pharmacology of Carboplatin in Ovarian Carcinoma Cells
Katano, K., Safaei, R., Samimi, G., Holzer, A. K., Rochdi, M., & Howell, S. B. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.2.466 · Cited by 126
Identification of Genes That Mediate Sensitivity to Cisplatin
Niedner, H., Christen, R. D., Lin, X., Kondo, A., & Howell, S. B. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1153 · Cited by 126
The role of copper transporters in the development of resistance to Pt drugs
Safaei, R., Holzer, A. K., Katano, K., Samimi, G., & Howell, S. B. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.05.006 · Cited by 114
Organic Cation Transporters and their Pharmacokinetic and Pharmacodynamic Consequences
Choi, M., & Song, I. (2008) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.23.243 · Cited by 108
The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours
Hall, M. D., Alderden, R. A., Zhang, M., Beale, P. J., Cai, Z., Lai, B. C. H., Stampfl, A. P. J., & Hambley, T. W. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2006.01.011 · Cited by 98
Self-citation
Confocal Microscopic Analysis of the Interaction between Cisplatin and the Copper Transporter ATP7B in Human Ovarian Carcinoma Cells
Katano, K., Safaei, R., Samimi, G., Holzer, A. K., Tomioka, M., Goodman, M., & Howell, S. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0689 · Cited by 96
Modulation of cis‐diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3‐isobutyl‐1‐methylxanthine in sensitive and resistant human ovarian carcinoma cells
Mann, S. C., Andrews, P. A., & Howell, S. B. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910480613 · Cited by 95
Kinetics and mechanism of uptake of platinum-based pharmaceuticals by the rat small intestine
Binks, S. P., & Dobrota, M. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90400-f · Cited by 91
An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumours
Hicks, K., Ohms, S., van Zijl, P. L., Denny, W. A., Hunter, P. J., & Wilson, W. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.481 · Cited by 91
Reduced endocytosis and altered lysosome function in cisplatin-resistant cell lines
Chauhan, S. S., Liang, X., Su, A. W., Panandiker, A. S. P., Shen, D. W., Hanover, J. A., & Gottesman, M. M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600861 · Cited by 90
Solution Structure of a DNA Duplex Containing a cis -Diammineplatinum(II) 1,3-d(GTG) Intrastrand Cross-Link, a Major Adduct in Cells Treated with the Anticancer Drug Carboplatin
Teuben, J., Bauer, C., Wang, A. H. ‐., & Reedijk, J. (1999) · Biochemistry · doi:10.1021/bi9904757 · Cited by 79
Decreased cisplatin uptake by resistant L1210 leukemia cells
Hromas, R., North, J. A., & Burns, C. P. (1987) · Cancer Letters · doi:10.1016/0304-3835(87)90091-7 · Cited by 65
Element Array by Scanning X-ray Fluorescence Microscopy after Cis-Diamminedichloro-Platinum(II) Treatment
Shimura, M., Saito, A., Matsuyama, S., Sakuma, T., Terui, Y., Ueno, K., Yumoto, H., Yamauchi, K., Yamamura, K., Mimura, H., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0373 · Cited by 65
Elemental Tomography of Cancer-Cell Spheroids Reveals Incomplete Uptake of Both Platinum(II) and Platinum(IV) Complexes
Alderden, R. A., Mellor, H. R., Modok, S., Hall, M. D., Sutton, S. R., Newville, M. G., Callaghan, R., & Hambley, T. W. (2007) · Journal of the American Chemical Society · doi:10.1021/ja076281t · Cited by 60
Self-citation
Trafficking and localization of platinum complexes in cisplatin‐resistant cell lines monitored by fluorescence‐labeled platinum
Liang, X., Shen, D., Chen, K. G., Wincovitch, S., Garfield, S. H., & Gottesman, M. M. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20253 · Cited by 57
Improved targeting of platinum chemotherapeutics
Lin, X., Zhang, Q., Rice, J. R., Stewart, D. R., Nowotnik, D. P., & Howell, S. B. (2003) · European Journal of Cancer · doi:10.1016/j.ejca.2003.09.022 · Cited by 56
Cytotoxic efficacy of an anthraquinone linked platinum anticancer drug
Alderden, R. A., Mellor, H. R., Modok, S., Hambley, T. W., & Callaghan, R. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.039 · Cited by 53
Self-citation
Comparative efficacy of novel platinum(IV) compounds with established chemotherapeutic drugs in solid tumour models
Hall, M. D., Martin, C., Ferguson, D. J. P., Phillips, R. M., Hambley, T. W., & Callaghan, R. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.07.016 · Cited by 49
Self-citation
Dinuclear platinum anticancer complexes with fluorescent N,N′-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles
Kalayda, G. V., Jansen, B. A. J., Wielaard, P., Tanke, H. J., & Reedijk, J. (2005) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-005-0643-7 · Cited by 44
The role of metallothionein, glutathione, glutathione S-transferases and DNA repair in resistance to platinum drugs in a series of L1210 cell lines made resistant to anticancer platinum agents
Hrubisko, M., McGown, A. T., & Fox, B. W. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90399-h · Cited by 39
Differences in the cellular response and signaling pathways of cisplatin and BBR3464 ([{trans-PtCl(NH3)2}2μ-(trans-Pt(NH3)2(H2N(CH2)6-NH2)2)]4+) influenced by copper homeostasis
Kabolizadeh, P., Ryan, J., & Farrell, N. P. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.12.016 · Cited by 37
Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model
Modok, S., Scott, R., Alderden, R. A., Hall, M. D., Mellor, H. R., Bohic, S., Roose, T., Hambley, T. W., & Callaghan, R. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603854 · Cited by 34
Self-citation
Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo
Welters, M. J. P., Fichtinger-Schepman, A. M. J., Baan, R. A., Jacobs-Bergmans, A. J., Kegel, A., van der Vijgh, W. J. F., & Braakhuis, B. J. M. (1998) · British Journal of Cancer · doi:10.1038/sj.bjc.6690015 · Cited by 33
Stimulation of cis-diamminedichloroplatinum(II) accumulation by modulation of passive permeability with genistein: an altered response in accumulation-defective resistant cells.
Marverti, G., & Andrews, P. A. (1996) · PubMed · Cited by 29

Targeting and delivery of platinum-based anticancer drugs
Wang, X., & Guo, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35259a · Cited by 684
Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen Species
Ma, P., Xiao, H., Yu, C., Liu, J., Cheng, Z., Song, H., Zhang, X., Li, C., Wang, J., Gu, Z., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b04269 · Cited by 649
Stimuli-Responsive Therapeutic Metallodrugs
Wang, X., Wang, X., Jin, S., Muhammad, N., & Guo, Z. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00209 · Cited by 649
Novel Metals and Metal Complexes as Platforms for Cancer Therapy
Frezza, M., Hindo, S., Chen, D., Davenport, A., Schmitt, S., Tomco, D., & Ping Dou, Q. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791209009 · Cited by 552
Anticancer cyclometalated complexes of platinum group metals and gold
Cutillas, N., Yellol, G. S., de Haro, C., Vicente, C., Rodríguez, V., & Ruiz, J. (2013) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2013.03.024 · Cited by 332

See all 351

Authors: Klein, A. V., & Hambley, T. W.
Venue: Chemical Reviews
Publisher: American Chemical Society (ACS)
Published: 2009-08-28
Volume: 109
Issue: 10
Pages: 4911-4920
ISSN: 0009-2665 (ISSN-L)
1520-6890
DOI: 10.1021/cr9001066
OpenAlex: W2015112776
Cited by: 351
References: 68
FWCI: 1.78
Type: journal article
Language: en
Open access: closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Platinum Drug Distribution in Cancer Cells and Tumors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources